Best of ASH & SABCS 2024, Portland (Breast Cancer Sessions) - Enduring Recorded Webcast

This continuing education activity, Best of ASH & SABCS 2024, Portland (Breast Cancer Sessions) - Enduring Recorded Webcast, is recorded due to the cancellation of the live event that scheduled to be held on 01/13/2024. 

In this activity, Best of ASH & SABCS 2024, Portland (Breast Cancer Sessions) - Enduring Recorded Webcast, expert faculty place key abstract findings from the San Antonio Breast Cancer Symposium (SABCS2023) into clinical context and discuss how the results may change the current standards of care for patients with breast cancer. This webcast is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

The goals of this conference are to review and critically assess the results of practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients. 

    REGISTRATION FEES:

    This activity is free for all.

    Target Audience

    • Hematologists, Oncologists
    • Surgeons
    • Radiation Oncologists
    • Physician Assistants/Nurse Practitioners
    • Pharmacists
    • Nurses

    Organizing Committee

    Conference Director: 

    Binay Shah, MD, MHA - Binaytara Foundation

    Conference Co-Chairs:

    Sasha Stanton, MD, PhD - Providence Cancer Institute

    Curtis Lachowiez, MD - Oregon Health & Science University

    Learning Objectives

    1. Review data presented at the SABCS2023 and discuss their applications in clinical settings.    
    2. Choose new therapeutic options for treating breast cancer, understanding appropriate indications and contraindications to these therapeutic approaches.
    3. Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in the standards of care in breast cancer.
    4. Integrate evolving diagnostic, prognostic, and therapeutic approaches to managing breast cancer patients.
    5. Individualize management of patients based on emerging data from clinical trials and evolving expert guidelines.

    GLOBAL ONCOLOGY PROJECT

    To learn more about our ongoing project building a 200-bed cancer hospital in Nepal:

    You may also be interested in

    Best of ASCO 2024, Portland

    This CME-accredited oncology conference, Best of ASCO 2024, Portland, is designed to improve the care of cancer patients by educating clinicians involved in cancer care.
    Summit on Cancer Health Disparities (SCHD24)

    This annual oncology conference, The Summit on Cancer Health Disparities (SCHD24), is one of the largest gatherings of cancer care professionals interested in cancer health disparities with a focus on achieving health equity.
    Course summary
    Available credit: 
    • 2.25 ABIM MOC II
      Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
    • 2.25 AMA PRA Category 1 Credit™
      The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 2.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
    • 2.25 Nursing Contact Hours
      Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.25 Contact Hours.
    Course opens: 
    01/24/2024
    Course expires: 
    01/24/2025
    Cost:
    $0.00

    The videos are placed in the following order. Feel free to view the content that is relevant to you.

    Participants should claim continuing education credits to the extent of their participation.

    One hour and five minutes – Session 4

    25 minutes - Pre-malignancy/high risk breast cancer - Alison K. Conlin, MD, MPH

    Coming soon: Hormone receptor positive breast cancer - Evie A. Hobbs, MD

    20 minutes - HER2 positive breast cancer - David B. Page, MD

    20 minutes - Triple negative and HER2 low breast cancer - Nora Bucher, MD

    One hour and fifteen minutes – Session 5

    25 minutes - Radiotherapy – best breast practice - Kiri Cook, MD

    20 minutes - Updates in surgical approach – best breast practice - Kristen P. Massimino, MD

    10 minutes - Case 1 - DCIS - Sasha E. Stanton, MD, PhD

    5 minutes - Case 2 - Inflammatory breast cancer - Janet C. Ruzich, DO

    10 minutes - Case 3 - Early stage breast cancer - Kathleen Dunham, MD

    5 minutes - Case 4 - Early stage breast cancer - Sasha E. Stanton, MD, PhD

    IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

    All conflict of interest has been identified and mitigated for individuals in control of contents.

    PLANNING COMMITTEE DISCLOSURE STATEMENT:

    None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

    COURSE DIRECTOR(S)

    Binay Shah, MD, MHA has no relevant financial relationships to disclose at this time.

    CONFERENCE CHAIR(S)

    Sasha Stanton, MD PhD has a financial relationship (Grant Or Contract) with IMV Inc; financial relationship (Professional Services) with Stanford Prebys Burnham.

    Curtis Lachowiez, M.D. has a financial relationship (Independent contractor) with COTA Healthcare.

    SPEAKER/TOPIC PRESENTER(S)

    Nora Bucher, MD has a financial relationship (Professional Services) with Stemline; financial relationship (Professional Services) with Genentech.

    Alison Conlin, Md, Mph has no relevant financial relationships to disclose at this time.

    Kiri Cook, MD has no relevant financial relationships to disclose at this time.

    Evthokia Hobbs, MD has no relevant financial relationships to disclose at this time.

    Kristen Massimino, MD FACS, FSSO has no relevant financial relationships to disclose at this time.

    David Page, MD has a financial relationship (Independent contractor) with Novartis; financial relationship (Independent contractor) with Brooklyn Immunotherapeutics; financial relationship (Independent contractor) with Sanofi; financial relationship (Grant Or Contract) with Merck; financial relationship (Grant Or Contract) with WindMIL; financial relationship (Independent contractor) with Merck; financial relationship (Independent contractor) with NGM Bio; financial relationship (Independent contractor) with Clinical Care Options; financial relationship (Grant Or Contract) with Brooklyn Immunotherapeutics; financial relationship (Independent contractor) with Oncocyte; financial relationship (Independent contractor) with Lilly; financial relationship (Independent contractor) with Astrazeneca/D-S; financial relationship (Independent contractor) with Genentech; financial relationship (Independent contractor) with Sanford Burnham Presbys; financial relationship (Professional Services) with Biotheranostics; financial relationship (Grant Or Contract) with BMS.

    CASE PRESENTER(S)

    Kathleen Dunham has no relevant financial relationships to disclose at this time.

    Janet Ruzich has no relevant financial relationships to disclose at this time.

    Sasha Stanton, MD PhD has a financial relationship (Grant Or Contract) with IMV Inc; financial relationship (Professional Services) with Stanford Prebys Burnham.

    Available Credit

    • 2.25 ABIM MOC II
      Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
    • 2.25 AMA PRA Category 1 Credit™
      The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 2.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
    • 2.25 Nursing Contact Hours
      Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.25 Contact Hours.

    Price

    Cost:
    $0.00
    Please login or register to take this course.

    REGISTRATION FEES:

    This activity is free for all